Model JTL-T-01 - Pipeline Stem Cell Therapeutic Product
From Medical Products
Based on our platform and technology, Jointechlabs is developing therapies for unmet medical needs. Our first therapeutic in clinical development JTL-T-01 is a proprietary injectable stem cell scaffold as a biologic therapy for osteoarthritis, for approval under the FDA’s fast-track program. JTL-T-01 has been designed as an autologous point-of-care therapy enabling the patient’s own stem cells to be locally injected into the affected joints. A portion of the pre-clinical study for JTL-T-01 is funded by the National Institutes of Health’s small business grant in collaboration with Rush University, Chicago.
Procedure
JTL-T-01 Therapy is a pipeline therapeutic product under clinical development which combines a unique method of stromal vascular fraction (SVF) extraction from fat and its embedment into injectable scaffold. JTL-T-01 has been designed as an autologous point-of-care therapy for osteoarthritis useful for mitigation of pain, inflammation and cartilage deterioration.
Customer reviews
No reviews were found for Model JTL-T-01 - Pipeline Stem Cell Therapeutic Product. Be the first to review!